As a pioneering business, Veriton Pharma manufactures a range of prescription medicines that are tailor-made to meet the specific clinical needs of our patients. Our notable expertise lies in the fields of epilepsy, neurology, and rare paediatric conditions such as inborn errors of metabolism (IEMs).

 

Information for patients

  • We are committed to developing licensed medicinal products for our patients. Our portfolio of licensed medications lies within the field of epilepsy. Find out more
  • Veriton Pharma provide a range of unlicensed therapy options for those patients whose clinical needs are not met by licensed medications. Find out more
  • We do not provide a list of our prescription medicinal products on this website due to legal restrictions on the information that a company can provide to the public concerning prescription medicines. However if you have been prescribed one of Veriton Pharma’s medicines and would like to access the reference materials, please contact Medical information who will be delighted to assist with your query
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Veriton Pharma Ltd.
Tel: + 44 (0) 1932 690325
Online: Contact Us

Licensed Products

We are committed to developing licensed medicinal products that meet the specific needs of our patients. Veriton Pharma’s portfolio of prescription medicines stems from our team’s deep expertise in the field of epilepsy.

Find out more

A Trusted Partner

We are always on the lookout for differentiated medicines and late-stage opportunities that could fit with our growing portfolio and can improve the standard of care for more patients around the world.

Find out more

Business & Employment Opportunities

We are better together! If you would like to become part of the Veriton Pharma team, we would love to hear from you. Likewise, if you are a pharmaceutical company interested in distributing our products in your country, please contact us.

Contact us